-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Scinai Immunotherapeutics Ltd. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2022 to Q1 2023.
- Scinai Immunotherapeutics Ltd. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$3.06M, a 177% decline year-over-year.
- Scinai Immunotherapeutics Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$9.38M, a 29.1% decline from 2022.
- Scinai Immunotherapeutics Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$7.27M, a 2.17% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)